Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term response of refractory primary cold agglutinin disease to eculizumab therapy.

× No keyword cloud information.

10 in total

1. Severe refractory idiopathic warm autoimmune haemolytic anaemia responsive to complement inhibition with eculizumab.

Authors: Lucy Neave; Andrew J Wilson; Maxine Lissack; Marie Scully
Journal: BMJ Case Rep Date: 2018-12-13

2. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.

Authors: L Rotenstein; A Nathan; I Ghobrial; J Antin; A Parnes
Journal: Bone Marrow Transplant Date: 2016-06-06 Impact factor: 5.483

Review 3. Complement cascade and kidney transplantation: The rediscovery of an ancient enemy.

Authors: Alberto Mella; Maria Messina; Antonio Lavacca; Luigi Biancone
Journal: World J Transplant Date: 2014-09-24

Review 4. Development of New Drugs for Autoimmune Hemolytic Anemia.

Authors: Zhengrui Xiao; Irina Murakhovskaya
Journal: Pharmaceutics Date: 2022-05-11 Impact factor: 6.525

5. Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Authors: Mark P Chao; Jison Hong; Christian Kunder; Laura Lester; Stanley L Schrier; Ravindra Majeti
Journal: Am J Hematol Date: 2014-07-11 Impact factor: 10.047

Review 6. Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Authors: Diana Wouters; Sacha Zeerleder
Journal: Haematologica Date: 2015-11 Impact factor: 9.941

7. Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial.

Authors: Alexander Röth; Martin Bommer; Andreas Hüttmann; Dörte Herich-Terhürne; Nils Kuklik; Jan Rekowski; Veronika Lenz; Hubert Schrezenmeier; Ulrich Dührsen
Journal: Blood Adv Date: 2018-10-09

8. Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy.

Authors: Kim Ma; Stephen Caplan
Journal: Case Rep Hematol Date: 2016-03-22

9. Recurrent Viral Infections Complicated with Cold Agglutinin Disease after Splenectomy for Thrombocytopenia.

Authors: Hui-Ping Shi; Zhao-Yue Wang
Journal: Chin Med J (Engl) Date: 2018-01-20 Impact factor: 2.628

Review 10. Complement, a target for therapy in inflammatory and degenerative diseases.

Authors: B Paul Morgan; Claire L Harris
Journal: Nat Rev Drug Discov Date: 2015-10-23 Impact factor: 112.288

10 in total